Akèy › Maladi Crohn › Rhode Island › Providence
Etid klinik pou Maladi Crohn nan Providence, RI
12 etid pou Maladi Crohn ap chèche patisipan nan sit nan ak bò kote Providence (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Ap rekriteFaz 3
- University Gastroenterology - Providence - West River Street ( Site 5057), Providence
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Ap rekriteFaz 2
- University Gastroenterology - Providence - Staniford Street /ID# 280919, Providence
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Ap rekriteFaz 4
- University Gastroenterology, Providence
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 2/3
- University Gastroenterology, Providence
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 2
- University Gastroenterology Providence, Providence
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Ap rekriteFaz 3
- University Gastroenterology, Providence
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- University Gastroenterology-Site Number: 8400103, Providence
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- University Gastroenterology - GI Alliance-Site Number: 8400103, Providence
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Ap rekriteFaz 4
- University Gastroenterology, Providence
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Ap rekrite
- Gastroenterology Associates, Providence
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
Ap rekriteFaz 4
- Rhode Island Hospital, Providence
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Ap rekriteFaz 2
- Mirador Therapeutics Selected Site, Providence
Etid Maladi Crohn nan lòt vil
- New York City, NY35 etid
- Cleveland, OH19 etid
- St. Louis, MO19 etid
- Boston, MA19 etid
- Miami, FL19 etid
- Orlando, FL17 etid
- Houston, TX17 etid
- Atlanta, GA17 etid
- Tyler, TX16 etid
- San Diego, CA15 etid
- San Antonio, TX15 etid
- Los Angeles, CA15 etid
Lòt etid nan Providence
- Kansè ovè15 etid
- Kansè Endomèt14 etid
- Obèsite14 etid
- Kansè Poumon ki pa ti selil12 etid
- Kansè (tout kalite)12 etid
- Kolit Ulseratif11 etid
- Kansè nan tete11 etid
- Leksemi mieloïd egi10 etid
- Kansè Metastatik9 etid
- Sipwa9 etid
- Maladi Alzheimer8 etid
- Twoub Konsomasyon Alkòl (AUD)8 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.